All - Tozaro

Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector

May 1, 2025

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing today announced the appointment of Dr. Jason Slingsby MBA as Chief Executive Officer, effective 22 April 2025.

Affinity enrichment and femtomole detection of spike protein using smart polymers

January 17, 2025

By Keli

This research poster LC-MS Detection of SARS-Cov2 Spike Protein using Smart Polymers emphasises the possibility of using smart polymers for …

Development of VSV-G Smart Polymers for Lentivirus Quantification: from in silico modelling to application

January 17, 2025

By Keli

3 new prototypes for the detection of in-tact lentivirus were made and evaluated in just 4 months. This shows that …

Novel synthetic affinity reagents for lentivirus analytics and capture chromatography – Presented at The Bioprocessing Summit 2024

August 30, 2024

By Keli

First presented at The Bioprocessing Summit 2024, this poster introduces a new suite of synthetic affinity reagents targeting VSV-G, a …

MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification

August 5, 2024

By Keli

Bedfordshire, UK, 06 August 2024: MIP Discovery today announced the Company’s rebrand to Tozaro, completing its transition to becoming a …

Developing new tools for rapid quantification of viral vectors – a proof of concept

March 20, 2024

By celf_admin

This is the excerpt display This is the excerpt display This is the excerpt display This is the excerpt display This is the excerpt display This is the excerpt display This is the excerpt display This is the excerpt display

Tozaro closes £7M Series A financing to drive commercialization in cell and gene therapy space

February 19, 2024

By celf_admin

Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making …

Tozaro (formally MIP Discovery) secures significant funding to support development of global rapid response diagnostics

February 1, 2023

By celf_admin

Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale …

Fill in the form below to complete your download